📰 Polypid Ltd News
Polypid Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Polypid Ltd. Real-time updates on events, politics, business and more.
June 10, 2024
PETACH TIKVA, Israel, June 10, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to…
June 1, 2024
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report)’s stock price rose 0.2% during mid-day trading on Thursday . The company traded as high as $4.67 and last traded at $4.50. Approximately 5,148 shares traded hands during trading, a decline of 9% from the average daily volume of 5,662 shares. The stock had previously closed at $4.49. […]
June 1, 2024
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) rose 0.2% on Thursday . The stock traded as high as $4.67 and last traded at $4.50. Approximately 5,148 shares changed hands during mid-day trading, a decline of 9% from the average daily volume of 5,662 shares. The stock had previously closed at $4.49. Wall Street Analyst Weigh […]
May 31, 2024
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) shares traded up 0.2% during trading on Thursday . The stock traded as high as $4.67 and last traded at $4.50. 5,148 shares were traded during mid-day trading, a decline of 9% from the average session volume of 5,662 shares. The stock had previously closed at $4.49. Analyst […]
May 28, 2024
Has released an update. PolyPid Ltd. has announced its Annual and Extraordinary General Meeting of Shareholders, scheduled for July ...
May 5, 2024
HC Wainwright reaffirmed their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, Q3 2025 earnings […]
May 5, 2024
HC Wainwright reiterated their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, […]
April 11, 2024
PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Earnings and Valuation This table compares PolyPid and […]
April 11, 2024
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares LeMaitre Vascular […]
April 9, 2024
PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of recent […]